"La Caixa" Foundation will allocate €150,000 to the project led by Alba Rodríguez, from the IDIBAPS Cellular Immunotherapies for Cancer research group. It involves a study that aims to develop a ne...
Read moreCuando las células de sarcoma de Ewing son infectadas por el adenovirus terapéutico, estas expresan el gen ‘suicida’ HSV-TK. Este gen es inocuo, pero cuando se combina con la prodroga ganciclovi...
Read moreThe study, published in Molecular Oncology, reveals that the gene TCF19 plays a critical role in prostate cancer progression, tumor growth, and metastatic spread, highlighting its potential as a progn...
Read moreFreeOx has developed the first cerebroprotective therapy designed to preserve the brain during acute ischemic stroke. It is the key piece in stroke treatment, as it focuses on microcirculation and sol...
Read moreInvestigadores del Cima Universidad de Navarra demuestran que una nueva estrategia para activar linfocitos ‘natural killer’ disminuye significativamente el tumor en modelos animales
Read moreDeveloped under the principles of green chemistry, PLH is the first biocompatible, thermosetting and highly flexible copolyester on the market obtained from 100% bio- based raw materials. It is emergi...
Read moreThe project, in collaboration with ICFO, will study how pH regulates the assembly and activity of disordered proteins in neuronal cells.
Read moreHan desarrollado transportadores que les permiten captar eficazmente esos nutrientes disponibles en el entorno tumoral. En este contexto, al administrar un tratamiento de inmunoterapia con células CA...
Read moreThe Ophthalmology Department of Hospital de Sant Pau, together with the Ophthalmology Research Group of the Sant Pau Research Institute (IR Sant Pau), has recently participated in an international cli...
Read moreNiños y adultos con cardiopatías congénitas podrían beneficiarse pronto de una nueva técnica de estimulación cardíaca que imita el funcionamiento natural del corazón. El estudio, liderado por ...
Read moreOna Therapeutics is a pioneer in the development of first-in-class antibody-drug conjugates (ADCs) that leverage the molecular basis of advanced cancer. Through collaboration with academic and clinica...
Read moreThe findings may help explain why men and smokers are more likely to develop bladder cancer.
Read more